Apellis Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 2,415 | 0.0% | 96,125 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,163 | 0.0% | 95,595 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 1,582 | 0.0% | 91,408 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 2,008 | 0.0% | 91,818 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 2,930 | 0.0% | 91,818 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 2,648 | 0.0% | 91,818 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 3,522 | 0.0% | 91,818 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 1,855 | 0.0% | 28,116 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 5,039 | 0.0% | 84,178 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 2,383 | 0.0% | 62,636 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 5,692 | 0.0% | 62,486 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 1,855 | 0.0% | 28,116 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 1,454 | 0.0% | 28,116 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 1,910 | 0.0% | 27,966 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 1,265 | 0.0% | 27,966 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 1,362 | 0.0% | 26,796 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 1,267 | 0.0% | 26,796 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 883 | 0.0% | 26,796 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 1,694 | 0.0% | 26,796 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 1,025 | 0.0% | 23,895 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 1,385 | 0.0% | 24,215 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 752 | 0.0% | 24,915 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 741 | 0.0% | 22,695 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 548 | 0.0% | 20,447 | 3/31/2020 |
| 2019 Q4 | 2/3/2020 | 531 | 0.0% | 17,347 | 12/31/2019 |